Cargando…

Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice

Renal cell carcinoma (RCC) encompasses a wide spectrum of morphologically and molecularly distinct (>10) cancer subtypes originated from the kidney epithelium. Metastatic RCC (mRCC) is lethal and refractory to conventional chemotherapeutic agents. The incorporation of targeted therapies and immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casuscelli, Jozefina, Vano, Yann-Alexandre, Fridman, Wolf Herve, Hsieh, James J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179110/ https://www.ncbi.nlm.nih.gov/pubmed/30334000 http://dx.doi.org/10.3233/KCA-170008

Ejemplares similares

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
por: Becht, Etienne, et al.
Publicado: (2015)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice
por: Huang, Jennifer J., et al.
Publicado: (2020)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022)

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
por: Fournier, Laure, et al.
Publicado: (2017)

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
por: Lu, Xiaofan, et al.
Publicado: (2023)

Resistance to cancer immunotherapy in metastatic renal cell carcinoma
por: Moreira, Marco, et al.
Publicado: (2020)

Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma—A Retrospective, Single Center Analysis
por: Rodler, Severin, et al.
Publicado: (2022)

Safety and Efficacy of Robotic Radiosurgery for Visceral and Lymph Node Metastases of Renal Cell Carcinoma: A Retrospective, Single Center Analysis
por: Rodler, Severin, et al.
Publicado: (2021)

Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany?
por: Rodler, Severin, et al.
Publicado: (2020)

Integrating tumor microenvironment with cancer molecular classifications
por: Becht, Etienne, et al.
Publicado: (2015)

Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies
por: Guillaume, Zoé, et al.
Publicado: (2022)

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
por: Simonaggio, Audrey, et al.
Publicado: (2021)

Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics
por: Westhofen, Thilo, et al.
Publicado: (2020)

The clinical role of the TME in solid cancer
por: Giraldo, Nicolas A., et al.
Publicado: (2018)

Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma
por: Petitprez, Florent, et al.
Publicado: (2021)

Partial Nephrectomy in pT3a Tumors Less Than 7 cm in Diameter Has a Superior Overall Survival Compared to Radical Nephrectomy
por: Ziegelmueller, Brigitte K, et al.
Publicado: (2019)

Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population
por: Tamalunas, Alexander, et al.
Publicado: (2022)

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
por: Carril-Ajuria, Lucia, et al.
Publicado: (2022)

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
por: Tirino, Giuseppe, et al.
Publicado: (2018)

Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?
por: Rodler, Severin, et al.
Publicado: (2022)

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
por: Elaidi, Reza, et al.
Publicado: (2020)

Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder
por: Eismann, Lennert, et al.
Publicado: (2022)

Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities
por: Taverna, Cecilia, et al.
Publicado: (2022)

Network analysis of genes regulated in renal diseases: implications for a molecular-based classification
por: Bhavnani, Suresh K, et al.
Publicado: (2009)

Frontiers in Tumor Immunity: Grand Challenge “Cancer and Immunity: A Family Drama”
por: Fridman, Wolf-Hervé
Publicado: (2011)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
por: Vano, Yann-Alexandre, et al.
Publicado: (2021)

The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians
por: Bhowmik, D. M., et al.
Publicado: (2010)

Redox Metabolism-Associated Molecular Classification of Clear Cell Renal Cell Carcinoma
por: Wei, Xiangling, et al.
Publicado: (2022)

A Modern Approach to Endometrial Carcinoma: Will Molecular Classification Improve Precision Medicine in the Future?
por: Marnitz, Simone, et al.
Publicado: (2020)

Chromosomal aberrations in renal cell carcinoma: An overview with implications for clinical practice
por: Quddus, Muhammad Bilal, et al.
Publicado: (2019)

Implication of cystic fluid cytology of renal cell carcinoma on surgical practice
por: Hur, Kyung Jae, et al.
Publicado: (2022)

Endometrial cancer: molecular classification and future treatments
por: Corr, Bradley, et al.
Publicado: (2022)

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

Cabozantinib‐nivolumab sequence in metastatic renal cell carcinoma: The CABIR study
por: Vano, Yann‐Alexandre, et al.
Publicado: (2022)

Components of functional diversity revisited: A new classification and its theoretical and practical implications
por: Schmera, Dénes, et al.
Publicado: (2023)

Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy
por: Wang, Lisha, et al.
Publicado: (2014)

Covid-19 and implications for future practice
por: Jull, Gwendolen, et al.
Publicado: (2022)

Recent advances in cutaneous lymphoma—implications for current and future classifications
por: Goodlad, JR, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73qsv52uf5io8oueuvhv12f6ua